Results 1 to 10 of about 76,116 (300)

Discovery of novel serum peptide biomarkers for cholangiocarcinoma recurrence through MALDI-TOF MS and LC–MS/MS peptidome analysis

Scientific Reports
Cholangiocarcinoma (CCA) is an aggressive cancer originating from bile duct epithelial cells, with a high rate of recurrence following surgical resection. Recurrence is categorized as early linked to aggressive tumor biology than late recurrence.
Vasin Thanasukarn, Piya Prajumwongs, Nattha Muangritdech, Watcharin Loilome, Nisana Namwat, Poramate Klanrit, Arporn Wangwiwatsin, Sawanya Charoenlappanit, Janthima Jaresitthikunchai, Sittiruk Roytrakul, Attapol Titapun   +10 more
doaj   +1 more source

Inhibition of -type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment

Tumor Biology, 2017
Unlike normal cells, cancer cells undergo unlimited growth and multiplication, causing them to require massive amounts of amino acid to support their continuous metabolism. Among the amino acid transporters expressed on the plasma membrane, l- type amino
Supak Yothaisong, Hasaya Dokduang, Naohiko Anzai, Keitaro Hayashi, Nisana Namwat, Puangrat Yongvanit, Sakkarn Sangkhamanon, Promsuk Jutabha, Hitoshi Endou, Watcharin Loilome   +9 more
doaj   +1 more source

Cholangiocarcinoma. Epidemiology, classification, diagnosis, treatment methods (literature review)

Cholangiocarcinoma ranks second in the prevalence among primary malignant neoplasms of the liver. The paper discusses epidemiology, classification, risk factors of the disease, as well as the treatment approaches used all over the world, including ...
Artem A. Vovchenko, Leonid O. Petrov, Valery V. Kucherov, Alexandra G. Zamotina, Artur P. Petrosyan, Natalia A. Falaleeva   +5 more
core   +1 more source

Contrast enhanced ultrasound in mixed hepatocellular cholangiocarcinoma: Case series and review of the literature. [PDF]

, 2018
BACKGROUND Mixed hepatocellular cholangiocarcinoma is a rare form of primary liver cancer. AIMS The aim of this study is to report the results of the use of contrast enhanced ultrasound in a series of patients with confirmed mixed hepatocellular
Dong, Yi, Cui, Xin Wu, Annalisa Berzigotti, Berzigotti, Annalisa, Andreas Teufel, Christoph F. Dietrich, Teufel, Andreas, Trojan, Jörg, Xin Wu Cui, Dietrich, Christoph F, Jörg Trojan, Yi Dong   +11 more
core   +1 more source

Epidemiology of cholangiocarcinoma

European Journal of Surgical Oncology
Cholangiocarcinoma (CCA) represents a heterogenous set of malignancies arising from the biliary tract. Classification of CCA subdivides tumours into intrahepatic (iCCA) and extrahepatic (eCCA), with eCCA further categorised as perihilar (pCCA) and distal (dCCA) lesions. Tumour subtypes show distinct epidemiological, genetic and clinical characteristics.
Maria Qurashi, Mathew Vithayathil, Shahid A. Khan   +2 more
openaire   +2 more sources

Laparoscopic Resection of Hilar Cholangiocarcinoma [PDF]

, 2012
Background: Surgical resection is the only curative treatment for hilar cholangiocarcinoma. Laparoscopic hepatectomy has been used to treat several types of liver neoplasms.
Machado, Marcel Autran C., Mochizuki, Miki, Makdissi, Fabio F., Surjan, Rodrigo C.   +3 more
core   +1 more source

Indoleamine 2,3-dioxygenase 1 expression predicts cholangiocarcinoma patient survival

Experimental and Molecular Pathology
Background: Cholangiocarcinoma (CCA) is a prevalent hepatobiliary disease in northeast Thailand, where late diagnosis and limited treatment options contribute to poor prognosis.
Mallika Naeklang, Hasaya Dokduang, Piya Prajumwongs, Poramate Klanrit, Arporn Wangwiwatsin, Nisana Namwat, Attapol Titapun, Prakasit Sa-Ngiamwibool, Watcharin Loilome   +8 more
doaj   +1 more source

Retraction Note: Preclinical studies of toxicity and anti-cholangiocarcinoma activity of the standardized capsule formulation of atractylodes lancea (Thunb.) DC

BMC Complementary Medicine and Therapies
This article has been retracted.
Tullayakorn Plengsuriyakarn, Kanawut Kotawong, Juntra Karbwang, Kesara Na-Bangchang   +3 more
doaj   +1 more source

Incorporation of Microsatellite Instability and Tumor-Infiltrating Lymphocytes in Opisthorchis viverrini-Associated Cholangiocarcinoma: Predicting Patient Outcomes

Journal of Molecular Pathology
Background: Cholangiocarcinoma (CCA) has the highest incidence in Northeastern Thailand, where patients generally present with late diagnosis and poor prognosis.
Natcha Khuntikeo, Apiwat Jareanrat, Vasin Thanasukarn, Tharatip Srisuk, Vor Luvira, Watcharin Loilome, Poramate Klanrit, Anchalee Techasen, Jarin Chindaprasirt, Prakasit Sa-Ngiamwibool, Chaiwat Aphivatanasiri, Sureerat Padthaisong, Piya Prajumwongs, Attapol Titapun   +13 more
doaj   +1 more source

Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis

Redox Biology, 2018
Early B cell factor 1 (EBF1) is a transcription factor involved in the differentiation of several stem cell lineages and it is a negative regulator of estrogen receptors. EBF1 is down-regulated in many tumors, and is believed to play suppressive roles in
Napat Armartmuntree, Mariko Murata, Anchalee Techasen, Puangrat Yongvanit, Watcharin Loilome, Nisana Namwat, Chawalit Pairojkul, Chadamas Sakonsinsiri, Somchai Pinlaor, Raynoo Thanan   +9 more
doaj   +1 more source